期刊文献+

Imaging features and appropriate treatment strategy of a rare biliary tract neoplasm

Imaging features and appropriate treatment strategy of a rare biliary tract neoplasm
原文传递
导出
摘要 Mucin-producing bile duct tumors (MPBTs) are characterized by intraductal papillary tumorsproducing large amounts of mucin. The tumor comprises macroscopically prominent intraductal papillary neoplastic epithelia and produces a large amount of viscid mucin, resulting in dilatation of the bile ducts.1 These tumors of the peripheral bile duct, which include benign and malignant lesions, have also been referred to as intraductal growth- type peripheral cholangiocarcinomas,2 mucin-producing cholangiocellular carcinomas,3 intraductal papillary neoplasms (IPNs) of the biliary tract,4 IPNs of the liver,5 or IPNs of the bile duct.6 MPBTs have been the subject of recent attention due to its peculiar histopathology, biological and clinical behavior, varied radiological manifestations, and good prognosis of the patients] Due to the rarity of this disease entity and the non-specific clinical presentation, MPBTs are not well characterized. The purpose of this study was to define the precise diagnosis and correct management of MPBTs with the help of nine clinical cases observed in the last 10 years. The preoperative differential diagnosis, surgical procedure, and postoperative course of these nine cases were retrospectively reviewed. Mucin-producing bile duct tumors (MPBTs) are characterized by intraductal papillary tumorsproducing large amounts of mucin. The tumor comprises macroscopically prominent intraductal papillary neoplastic epithelia and produces a large amount of viscid mucin, resulting in dilatation of the bile ducts.1 These tumors of the peripheral bile duct, which include benign and malignant lesions, have also been referred to as intraductal growth- type peripheral cholangiocarcinomas,2 mucin-producing cholangiocellular carcinomas,3 intraductal papillary neoplasms (IPNs) of the biliary tract,4 IPNs of the liver,5 or IPNs of the bile duct.6 MPBTs have been the subject of recent attention due to its peculiar histopathology, biological and clinical behavior, varied radiological manifestations, and good prognosis of the patients] Due to the rarity of this disease entity and the non-specific clinical presentation, MPBTs are not well characterized. The purpose of this study was to define the precise diagnosis and correct management of MPBTs with the help of nine clinical cases observed in the last 10 years. The preoperative differential diagnosis, surgical procedure, and postoperative course of these nine cases were retrospectively reviewed.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第13期2573-2576,共4页 中华医学杂志(英文版)
关键词 biliary tract neoplasms mucin-producing bile duct tumors SURGERY PROGNOSIS biliary tract neoplasms, mucin-producing bile duct tumors, surgery, prognosis
  • 相关文献

参考文献16

  • 1Tsuchikawa T, Kondo S, Hirano S, Tanaka E, Anbo Y, Morikawa T, et al. Long-term survival after curative left hepatectomy for mucin-producing cholangiocarcinoma: report of a case. Surg Today 2005; 35: 256-258.
  • 2Suh KS, Roh HR, Koh YT, Lee KU, Park YH, Kim SW. Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 2000; 31: 12-17.
  • 3Chen MF, Jan YY, Chert TC. Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology- proven cases. Ann Surg 1998; 227: 63-69.
  • 4Abraham SC, Lee JH, Hruban RH, Argani P, Furth EE, Wu TT. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol 2003; 34: 902-910.
  • 5Chen TC, Nakanuma Y, Zen Y, Chen MF, Jan YY, Yeh TS, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 2001; 34:651-658.
  • 6Zen Y, Aishima S, Ajioka Y, Haratake J, Kage M, Kondo F, et al. Proposal of histological criteria for intraepithelial atypical/ proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol lnt 2005; 55: 180-188.
  • 7Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A, Yoshitomi H, et al. Surgical strategy for mucin-producing bile duct tumor. J Hepatobiliary Pancreat Sci 2010; 17: 236-240.
  • 8Shibahara H, Tamada S, Goto M, Oda K, Nagino M, Nagasaka T, et al. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol 2004; 28: 327-338.
  • 9Sano T, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Kanai M, et al. Clinical utility of percutaneous transhepatic cholangioscopy in defining tumor extent: a case of mucin-producing bile duct carcinoma originating in the left caudate lobe. Gastrointest Endosc 1997; 46: 455-458.
  • 10Sakamoto E, Hayakawa N, Kamiya J, Kondo S, Nagino M, Kanai M, et al. Treatment strategy for mucin-producing intrahepatic cholangiocarcinoma: value of percutaneous transhepatic biliary drainage and cholangioscopy. World J Surg 1999; 23: 1038-1043.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部